ACER - Acer Therapeutics Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development12,452.4248,725.0265,308.6621,957.967
Selling General and Administrative9,260.5835,223.1011,391.182611.194
Non Recurring----
Others----
Total Operating Expenses21,713.00713,948.1276,699.8442,569.161
Operating Income or Loss-21,713.007-13,948.127-6,699.844-2,569.161
Income from Continuing Operations
Total Other Income/Expenses Net432.116-246.3040.282-1,098.536
Earnings Before Interest and Taxes-21,713.007-13,948.127-6,699.844-2,569.161
Interest Expense-0.987-242.982-242.982-994.529
Income Before Tax-21,280.891-14,194.431-6,699.562-3,667.697
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-21,280.891-14,194.431-6,699.562-3,667.697
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-21,280.891-14,194.431-6,699.562-3,667.697
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-21,280.891-14,194.431-6,699.562-3,667.697